Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Vericel Corp | a57191exv31w1.htm |
| 10-K - FORM 10-K - Vericel Corp | a57191e10vk.htm |
| EX-21 - EX-21 - Vericel Corp | a57191exv21.htm |
| EX-32.1 - EX-32.1 - Vericel Corp | a57191exv32w1.htm |
| EX-31.2 - EX-31.2 - Vericel Corp | a57191exv31w2.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1
(No. 333-160044),
Forms S-3 (Nos. 333-155739, 333-108989 and 333-107579) and Forms S-8 (Nos. 333-121006, 333-115505, 333-81340, 333-51556, 333-38886, 333-140624 and 333-25021) of Aastrom
Biosciences, Inc. (a development stage company) of our report dated September 7, 2010 relating to
the consolidated financial statements and the effectiveness of internal control over financial
reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Detroit, Michigan
September 7, 2010
PricewaterhouseCoopers LLP
Detroit, Michigan
September 7, 2010